Dose-Response Relationship Study of Selenium Nanoparticles as an Immunostimulatory Agent in Cancer-bearing Mice

Archives of Medical Research

Volumn 46, Issue 1, 2015, Pages 31-37

  Faghfuri, Elnaz ^a   Yazdi, Mohamad Hossein ^a   Mahdavi, Mehdi ^a   Sepehrizadeh, Zargham ^a   Faramarzi, Mohammad Ali ^a   Mavandadnejad, Faranak ^a   Shahverdi, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast tumor; Life span; Preventive strategy; Selenium nanoparticles; Tumor growth

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; SELENIUM NANOPARTICLE; NANOPARTICLE; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER MODEL; CANCER PREVENTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; LIFESPAN; MOUSE; MOUSE MODEL; NONHUMAN; PARTICLE SIZE; SURVIVAL RATE; TUMOR GROWTH; TUMOR VOLUME; WEIGHT CONTROL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BREAST NEOPLASMS; CHEMOPROPHYLAXIS; DRUG EFFECTS; HUMAN; IMMUNOMODULATION; MORTALITY;

ANIMALS; BREAST NEOPLASMS; CHEMOPREVENTION; FEMALE; HUMANS; IMMUNOMODULATION; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; NANOPARTICLES; SELENIUM; SURVIVAL RATE;

EID: 84932649700     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2015.01.002     Document Type: Article

References (23)

1. Tanaka T., Decuzzi P., Cristofanilli M., et al. Nanotechnology for breast cancer therapy. Biomed Microdevices 2009, 11:49-63.
2. Misra R., Acharya S., Sahoo S.K. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today 2010, 15:842-850.
3. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
4. Siddiqui I.A., Adhami V.M., Ahmad N., et al. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer 2010, 62:883-890.
5. Schrauzer G.N. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr 2000, 130:1653-1656.
6. Cui Y., Vogt S., Olson N., et al. levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:1682-1685.
7. Clark L.C., Combs G.F., Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. J Am Med Assoc 1996, 276:1957-1963.
8. Song H., Hur I., Park H.J., et al. Selenium inhibits metastasis of murine melanoma cells through the induction of cell cycle arrest and cell death. Immune Netw 2009, 9:236-242.
9. Chen Y.C., Prabhu K.S., Das A., et al. Dietary selenium supplementation modifies breast tumor growth and metastasis. Int J Cancer 2013, 133:2054-2064.
10. Ip C., Birringer M., Block E., et al. Chemical speciation influencescomparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 2000, 48:2062-2070.
11. Yazdi M.H., Mahdavi M., Varastehmoradi B., et al. The immunostimulatory effect of biogenic selenium nanoparticles on the 4T1 breast cancer model: an invivo study. Biol Trace Elem Res 2012, 149:22-28.
12. Shakibaie M., Shahverdi A.R., Faramarzi M.A., et al. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm Biol 2013, 51:58-63.
13. Ferguson L.R., Philpott M. Cancer prevention by dietary bioactive components that target the immune response. Curr Cancer Drug Targets 2007, 7:459-464.
14. Wang D., Taylor E.W., Wang Y., et al. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. Int J Nanomed 2012, 7:1711-1721.
15. Lan Q., Zheng T., Rothman N., et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006, 107:4101-4108.
16. Rosenberg J., Chia Y.L., Plevritis S. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 2005, 89:47-54.
17. Hellman S. Karnovsky memorial lecture. Natural history of small breast cancers. J Clin Oncol 1994, 12:2229-2234.
18. Yazdi M.H., Mahdavi M., Setayesh N., et al. Selenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in-vivo and reduces the liver metastasis in metastatic form of mouse breast cancer. DARU J Pharm Sci 2013, 21:33.
19. Yazdi M.H., Mahdavi M., Kheradmand E., et al. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneim Forsch 2012, 62:525-531.
20. Yazdi M.H., Masoudifar M., Varastehmoradi B., et al. Effect of oral supplementation of biogenic selenium nanoparticles on white blood cell profile of BALB/c mice and mice exposed to X-ray radiation. Avicenna J Med Biotechnol 2013, 5:158-167.
21. Wang X., Sun K., Tan Y., et al. Efficacy and safety of selenium nanoparticles administered intraperitoneally for the prevention of growth of cancer cells in the peritoneal cavity. Free Radic Biol Med 2014, 72:1-10.
22. Sengupta J., Ghosh S., Datta P., et al. Physiologically important metal nanoparticles and their toxicity. J Nanosci Nanotechnol 2014, 14:990-1006.
23. Huang Y., He L., Liu W., et al. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials 2013, 34:7106-7116.